Clinical characteristics of a diffuse toxic goiter in men
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
Abstract
About the Authors
A F Romanchishendoktor med. nauk, professor, rukovoditel' Sankt-Peterburgskogo Tsentra endokrinnoy khirurgii, zav. kafedroy gospital'noy khirurgii s kursami travmatologii i VPKh SPbGPMU
V A Volert
kand. med. nauk, vrach-khirurg SPb GBUZ “Gorodskaya Mariinskaya bol'nitsa”
K V Vabalayte
assistent kafedry gospital'noy khirurgii s kursami travmatologii i VPKh SPbGPMU
A P Atabaev
vrach-khirurg SPb GBUZ “Gorodskaya Mariinskaya bol'nitsa"
References
1. Drachinskaya ES. K tekhnike subtotal'noi strumektomii u bol'nykh bazedovoi bolezn'yu. Vestnik khirurgii. 1948;5:18-24.
2. Kalinin AP. Diffuznyi toksicheskii zob u muzhchin. Informatsionnoe pis'mo dlya endokrinologov, terapevtov, khirurgov. M., 1994. 14 s.
3. Kotova GA. Diffuznyi toksicheskii zob. V kn.: Klinicheskaya endokrinologiya. SPb.: Piter, 2002:131-150.
4. Natarov VV, Tsarikovskaya NG, Karachentsev YuI, Chapai II. Khirurgicheskoe lechenie diffuznogo toksicheskogo zoba u lits pozhilogo i starcheskogo vozrasta. 2-i Vseros. s"ezd endokrinologov: tez. dokl. Chelyabinsk, 1991:278.
5. Panteleev IV, Kirillov YuB, Chumachenko PA, Aristarkhov VG. Morfofunktsional'noe obosnovanie ob"ema rezektsii shchitovidnoi zhelezy pri diffuznom toksicheskom zobe. Sovremennye aspekty khirurgicheskoi endokrinologii. Saransk, 1997:209-212.
6. Romanchishen AF. Khirurgiya shchitovidnoi i okoloshchitovidnykh zhelez. SPb.: IPK Vesti, 2009:647.
7. Dunhill TP. Surgical treatment of exophtalmic goiter. Aust Med Congress. 8th session, Melbourne. 1908;1:365-372.
8. Ladenson PW, Singer PA, Ain KB et al. American Thyroid Association Guidelines for Detection of Thyroid Dysfunction. Arch Intern Med. 2000;160:1573-1575.
9. Romaldini JH. Case selection and restrictions recommended to patients with hyperthyroidism in South America. Thyroid. 1997;7(2):225-228.
10. Tominaga T, Yokoyama N, Nagataki S et al. International differences in approaches to 131I therapy for Graves' disease: case selection and restrictions recommended to patients in Japan, Korea, and China. Clin Endocrinol (Oxf). 1998; 49(1):21-28.
11. Walsh JP. Management of Graves' disease in Australia. Aust N Z J Med. 2000;30(5):559-566.
Review
For citations:
Romanchishen A.F., Volert V.A., Vabalayte K.V., Atabaev A.P. Clinical characteristics of a diffuse toxic goiter in men. Endocrine Surgery. 2013;7(4):14-20. (In Russ.)
ISSN 2310-3965 (Online)